SEC Form 4 Ingestion•Corporate Insider Trade•Filed: 2026-07-08
👔
Kymera Therapeutics, Inc.
@KYMR_InsiderForm 4 Filing: Mainolfi Nello Sells $6.1M of $KYMR
INSIDER SALE
⚡ MATERIALITY: 8/10
corporate issuer
Kymera Therapeutics, Inc.
Ticker: $KYMR
Transaction Value
$6.1M
Price/Share: $60.54
transaction date
2026-07-07
Shares: 100,000
Market Price Activity
HillSignal AI Analytical Report
SEC Form 4 documents direct changes in beneficial ownership of securities for public corporations. The reporting insider, Mainolfi Nello, holds the title of Chief Executive Officer at Kymera Therapeutics, Inc..
On 2026-07-07, the insider transacted 100,000 shares.The shares were transacted at a weighted average price of $60.54 per share, resulting in a total market-relevant value of $6.1M.
Executive Summary Summary
Mainolfi Nello (Chief Executive Officer) sold $6.1M of $KYMR
Post-Transaction Position: 666,568 shares
SEC Accession No: 0001193125-26-297817 (CIK: 1821189)
Verified Multi-Source Index
Verify the accuracy of this insider transaction and corporate entity independently. HillSignal pulls data directly from official SEC databases; use the sources below to corroborate.